Rambus Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 57.3% to $1.94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.3%, from $1.23M to $1.94M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $520.00K | $5.18M | $3.46M | $4.44M | $4.40M | $476.00K | $478.00K | $462.00K | $5.43M | $5.42M | $5.43M | $1.23M | $1.23M | $1.23M | $1.94M |
| QoQ Change | — | +896.2% | -33.2% | +28.1% | -0.8% | -89.2% | +0.4% | -3.3% | >999% | -0.1% | +0.2% | -77.3% | +0.0% | +0.0% | +57.3% |
| YoY Change | — | — | — | +752.9% | -15.1% | -86.3% | -89.2% | -89.5% | >999% | >999% | >999% | -77.3% | -77.3% | -77.3% | +57.3% |